Ko Yo Group Maintains 7.03 Billion Outstanding Shares in March 2026 Monthly Return

Bulletin Express
Mar 31

Ko Yo Chemical (Group) Limited (Ko Yo Group) filed its Monthly Return for the period ended 31 March 2026, confirming stability in both authorised and issued share capital.

Authorised Share Capital • Authorised share capital remained unchanged at HKD 2.00 billion, representing 20.00 billion ordinary shares with a par value of HKD 0.10 each.

Issued Share Capital and Public Float • Issued share count stayed flat at 7.03 billion shares. • The company reported zero treasury shares and confirmed compliance with the Main Board’s minimum 25 % public-float requirement.

Equity Incentives • Share options outstanding totalled 63.99 million, split between: – 1.50 million options at HKD 0.151 expiring 21 June 2026. – 62.49 million options at HKD 0.182 expiring 21 November 2031. • No options were exercised during the month, and no new options were granted.

Convertible Instruments • Convertible bonds outstanding were unchanged at HKD 723.60 million, convertible at HKD 0.108 per share. • Full conversion would allow the issuance of up to 6.70 billion new shares, implying a potential dilution of 48.78 % relative to current outstanding shares.

Overall Movement • The month recorded no changes in authorised capital, issued shares, treasury shares, warrants, or other equity-linked instruments. The capital structure therefore remained stable through March 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10